Alpa Laboratories Limited
Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals
What Alpa files
- Others26
- Board Meeting10
- Important7
- Results3
- Insider Trade3
- Dividend/Bonus2
Alpa Laboratories has revised its financial results filing for Q4 FY26 (ended March 31). This update clarifies or modifies previously shared financial figures.
Alpa Laboratories Ltd. has clarified discrepancies related to its financial results for the quarter ended December 31, 2024, submitted to the NSE. The company acknowledged an inadvertent omission of comparative figures for the previous nine months and a typographical error related to the auditor's limited review report. The revised financial...
Alpa Laboratories Ltd. has announced a board meeting to discuss the integrated filing of financial results for the quarter and nine months ended 31st December 2024. Key figures reveal standalone revenue from operations at ₹2,615.02 lakh, with total income reaching ₹3,495.19 lakh. However, profit before tax dropped to ₹89.30 lakh,...